Information for CagriSema
Page information·measured at build time
Technical and provenance information about CagriSema. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | CagriSema |
|---|---|
| Default sort key | CagriSema |
| Namespace | Article (main) |
| Page kind | Compound |
| Page length (source, bytes) | 5,687 |
| Rendered word count | 685 |
| Internal wiki links on the page | 26 |
| Defined citations | 4 |
| Top-level sections | 3 |
| Subsections | 0 |
| Tables | 0 |
| Figures | 0 |
| Infobox | Yes — compound |
| Maintenance banners | update |
| Indexing by robots | Allowed |
Edit history
| Page creator | MergeMorwenna |
|---|---|
| Date of page creation | 18 October 2024 |
| Latest editor | CuriousCallum |
| Date of latest edit | 16 July 2026 |
| Total number of edits | 31 |
| Total number of distinct authors | 30 |
| Minor edits | 12 |
| Automated (bot) edits | 2 |
| Recent number of edits (last 90 days) | 3 |
| Talk page posts | 7 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| OrforglipronOona | 2 | 6.5% | GLP-1 receptor agonists and related compounds |
| MergeMorwenna | 1 | 3.2% | policy, notability and deletion |
| LiraLotte | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
| TirzTaxonomist | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
| DulaglutideDug | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
| LabRangeLindy | 1 | 3.2% | laboratory medicine and biomarkers |
| ExenatideEzra | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
| SemaglutideSasha | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
| UnderfillUna | 1 | 3.2% | third-party testing and certificates of analysis |
| Hedgerow_Hal | 1 | 3.2% | copy-editing and the manual of style |
| ComparisonCato | 1 | 3.2% | GLP-1 receptor agonists and related compounds |
| StubSorterBot | 1 | 3.2% | categorisation and navigation |
Category membership
- Category:Amylin analogues — 4 member pages
- Category:Peptide drugs — 17 member pages
- Category:Articles needing updates — 6 member pages
- Category:Articles describing unapproved compounds — 21 member pages
- Category:Articles needing updates (maintenance)